Patents by Inventor Guy BERCHEM

Guy BERCHEM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR DETECTION OF LUNG CANCER
    Publication number: 20230213521
    Abstract: The application discloses in vitro methods for diagnosing lung cancer in a subject, wherein the method comprises detecting at least one biomarker selected from the group consisting of Rho GDP dissociation inhibitor beta (ARHGDIB), alpha-tubulin 4A (TUBA4A), glutathione S-transferase omega 1 (GSTO1), filamin A (FLNA), peroxiredoxin 6 (PRDX6) and cadherin 13 (CDH13) in a biological sample from the subject, and kits for measuring said at least one biomarker.
    Type: Application
    Filed: April 28, 2021
    Publication date: July 6, 2023
    Applicants: Luxembourg Institute of Health (LIH), Fred Hutchinson Cancer Center, The Translational Genomics Research Institute (TGEN)
    Inventors: Victoria EL KHOURY, Anna Elisabeth SCHRITZ, Yeoun Jin KIM, Guy BERCHEM, Amanda PAULOVICH, Jeffrey WHITEAKER, Konstantinos PETRITIS, Patrick PIRROTTE, Tony TEGELER
  • Specific ACKR2 Modulators for Use in Therapy
    Publication number: 20220348667
    Abstract: The application discloses a specific ACKR2 modulator for use in the treatment of a proliferative disease or disorder in a subject and/or for use in improving the response of a subject to anticancer immunotherapy. The application further discloses pharmaceutical compositions comprising such a specific ACKR2 modulator and one or more immune checkpoint modulators, preferably one or more immune checkpoint inhibitors.
    Type: Application
    Filed: July 15, 2020
    Publication date: November 3, 2022
    Applicant: Luxembourg Institute of Health (LIH)
    Inventors: Bassam Janji, Muhammad Zaeem Noman, Andy Chevigné, Martyna Szpakowska, Guy Berchem, Markus Ollert
  • Diagnosis and treatment of chronic lymphocytic leukemia (CLL)
    Patent number: 8828963
    Abstract: New markers in the form of miRNA levels in plasma are provided for indicating the presence of CLL in a subject as well as suggesting routes of therapeutic treatment.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: September 9, 2014
    Assignees: Institute for Systems Biology, Centre de Recherche Public de la Sante
    Inventors: David Galas, Kai Wang, Guy Berchem, Etienne Moussay
  • DIAGNOSIS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Publication number: 20120252871
    Abstract: New markers in the form of miRNA levels in plasma are provided for indicating the presence of CLL in a subject as well as suggesting routes of therapeutic treatment.
    Type: Application
    Filed: March 16, 2012
    Publication date: October 4, 2012
    Applicant: Institute For Systems Biology
    Inventors: David GALAS, Kai WANG, Guy BERCHEM, Etienne MOUSSAY